CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 312 enrolled
Drug / intervention
Lansoprazole +4 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02175927
NCT02175927Phase 4Completed
CompareCT.gov

Prospective, Randomized Controlled Trial Comparing High Dose Amoxicillin Versus Tetracycline Based Quadruple Therapy as Second-line Treatment for Resistant Helicobacter Pylori Infection

Shanghai Jiao Tong University School of Medicine·interventional·Posted Jun 26, 2014·Updated Mar 1, 2016

In Brief

A Phase 4 clinical trial evaluating Lansoprazole, Bismuth Potassium Citrate, and 3 other interventions for Helicobacter Pylori Treatment Failure. Completed, enrolled 312 participants across 1 site.

Detailed Summary

No trial has examined the the efficacy of high dose amoxicillin based quadruple therapy as second-line treatment for Helicobacter pylori infection. The study aims to compare the effectiveness and safety of 14-day high dose amoxicillin-based quadruple regiment with classical quadruple regiment for rescue eradication of Helicobacter pylori.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHelicobacter Pylori Treatment Failure
CountriesChina
Collaborators--

Timeline

Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
First PostedJun 26, 2014
Enrollment StartJul 1, 2014
Primary CompletionOct 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 12.0 years ago

Interventions

Lansoprazoledrug

antisecretory drug of each quadruple therapy

Bismuth Potassium Citratedrug

one component of each quadruple therapy

Metronidazoledrug

antibiotic of each quadruple therapy

Amoxicillindrug

antibiotic of high dose amoxicillin based quadruple therapy

Tetracyclinedrug

antibiotic of classical quadruple therapy